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In a previous communication from this laboratory it was shown that the intra- 
venous injection of crude papain into young rabbits was followed by reversible 
depletion of cartilage matrix throughout the body with loss  of the basophilic 
staining property of cartilage (1).  Subsequently, Spicer and Bryant  described 
loss of metachromasia of cartilage and the appearance of basophilic material in 
pericartilaginous tissues shortly after an injection of crude papain (2).  Bryant, 
Leder, and Stetten demonstrated increased amounts of chondroitin sulfate-like 
material in the blood and urine of similarly  treated animals (3). Tsaltas reported 
that in rabbits previously given sulfur-35, which is incorporated largely into 
sulfated mucopolysaccharides, the administration of crude papain resulted in 
a rapid rise in blood and urine levels of Sac. Autoradiographs of cartilage from 
such animals showed reduction in activity compared with controls (4).  All of 
these findings indicate that crude papain causes the in vivo liberation of chon- 
droitin sulfate from cartilage. 
It was found that the purified crystalline papain protease could produce the 
same changes in cartilage, provided that the enzyme was injected in an inactive 
form. Active (reduced) papain protease, on the other hand, was found to have 
little or no effect on cartilage in vi~o following intravenous injection. It was pos- 
tulated that active papain reacts with one or more substrates in the blood and as 
a result fails to enter cartilage following intravenous injection; inactive papain, 
in contrast,  remains free  to diffuse out of the  circulation and into cartilage 
where it is activated (5, 6). 
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Commercially available crystalline papain is supplied in a  suspension con- 
taining cysteine. It was  found that  the  same in  vivo  effects  on cartilage oc- 
curred  following injection  of  this  material  whether  inactivated by  dialysis, 
which removes the cysteine and leads to oxidation to the disulfide form, or in- 
activated by treatment  with iodoacetamide.  Following treatment with  iodo- 
acetamide, no in vitro  enzymatic activity is restored  to  crystalline papain by 
the subsequent addition of a reducing agent such  as cysteine, and the inactiva- 
tion of papain by iodoacetamide is considered to be  irreversible. In view of the 
findings that depletion of cartilage matrix could be produced by the intravenous 
administration of papain treated with excess iodoacetamide, it was postulated 
that  there existed  in the rabbit a  mechanism which  could reactivate papain 
acetamide (5). 
In the present report,  the problem of the reactivation of papain treated with 
iodoacetamide has  been studied, and an alternative explanation has been found 
for the in vivo effects of this material. In addition, a study has been made of the 
factors determining the difference in behavior of active and inactive papain in 
rabbits. In this study a  new method has been employed for quantitating the 
amount of chondroitin sulfate released from cartilage. 
Materials and Methods 
Albino rabbits of either sex, weighing  between 800 and 1000 gm. were used. 
Crystalline papain  protease (recrystallized 2 times) was obtained  from Nutritional Bio- 
chemicals Corp., Freehold, New Jersey. The enzyme was supplied in phosphate buffer, pH 6.9, 
containing approximately 20 rag. of protease/ml, and 0.03 ~ cysteine. 
Antiserum to crystal]ine papain was prepared in rabbits immunized by two subcutaneous 
injections of 5 rag. crystalline papain with Freund's  complete adjuvant at an interval of 4 days, 
followed 1 week later by intravenous injections of I to 2 mg. of active crystalline papain thrice 
weekly for 4 weeks. The animals were bled 10 days after the last injection. After preliminary 
titration, the most active sera were pooled and analyzed by the quantitative precipitin tech- 
nique (7). 
Two pools of serum were prepared and these contained respectively 1.0 rag. and 4.0 mg. 
antibody/ml. The antigen:antibody  ratio at equivalence was 1  : 11. The amount of material 
precipitated following  addition of papain was the same for active and inactive papain in equal 
quantities, whether in antigen or antibody excess. On double diffusion in agar, a single pre- 
cipitin line formed between the antiserum and several different preparations of active or in- 
active papain. Thus it appeared that the antigenic determinants on the papain molecule were 
not significantly affected by procedures modifying the enzymatic activity of papain, and that 
the enzyme was a pure antigen. However, this antiserum formed several distinct precipitin 
lines on double diffusion  with crude papain, suggesting that the crystalline material contained 
sufficient  traces of other antigens at least to stimulate antibody  formation. 
For certain experiments papain was labelled as follows with iodine 131 (i131). A solution of 
100 mg. of crystalline papain diluted in normal saline to 20 ml. was dialyzed for 24 hours at 
4°C. with normal saline containing 0.001 M ethylene diamine tetraacetic  acid (EDTA),  re- 
sulting in removal of cysteine and oxidation of the enzyme to the inactive disulfide form. To 
the dialyzed papain was added 1 ml. of 0.05 ~ carbonate buffer, pH 10. A solution of carrier-free 
I TM, 2 me. in 2 ml., was added to 1 ml. Kin solution (I2, 0.123 gm., KI, 0.157 gm. in 100 ml. POTTER~  MCCLUSKEY~ WEISSMANN~  AND  THOMAS  1175 
H20) and the resulting mixture transferred to the buffered solution of papain. After 20 minutes 
at 4°C.,  the solution of papain was dialyzed for 3  days with four changes of normal saline 
(1 liter) at 4°C. This preparation was stored at 4°C.; aliquots used in experiments were dialyzed 
for 18 to 24 hours and after warming to 37°C. were centrifuged for 15 minutes at 2500 R.r.M. 
to remove traces of insoluble material. 
In vitro tests showed that 70 to 86 per cent of the original proteolytic activity could be re- 
stored to papain, following iodination, by addition of cysteine and EDTA. Solutions of papain 
reactivated by cysteine and EDTA or treated with iodoacetamide, or following incubation at 
37°C.  for 30 minutes,  contained only insignificant amounts of  dialyzable radioactivity.  Of 
the radioactivity in aqueous solutions of labeled papain, 85 to 89 per cent was present in  the 
material precipitated by a specific antiserum to crystalline papain. 
Two methods were used to measure the enzymatic activity of papain in vitro. The first was 
the method of Davis and Smith (8), using alpha benzol-L-argininamide (BAA) as the substrate. 
Reactions were run at pH. 7.0, at 37°C. using 0.05 ~s BAA. Under the conditions of assay the 
hydrolysis of BAA behaves as a  first order reaction. Specific  activity (C1) is expressed as  K1 
(first order rate constant calculated in decimal logarithms) per milligram of enzyme protein 
nitrogen per milliliter of reaction mixture. Because of the di~culty in detecting and measuring 
by this method small amounts of enzymatically active material, an alternative method of 
assay using I131-1abeled human serum albumin (HSA 1181) was devised. This procedure differs 
in detail from the method of assay for trypsin and chymotrypsin, using casein labeled with 1131 
described recently by Katchman, Zipf, and Homer  (9). I131-1abelled HSA was obtained from 
Abbott Laboratries, Inc., Teterboro, New Jersey, and was mixed with unlabeled HSA so that 
the radioactivity of 1 mg. of the protein mixture was approximately 20,000 c.r.~. The protein 
was made up in normal saline in a concentration of 5 mg./ml. At the start of the assay, 0.2 ml. 
of this solution was added to 1.8 ml. of 0.1 u  phosphate buffer, pH. 7, containing some or all of 
the reagents, papain, cysteine, and EDTA, in amounts described below. The reaction mixtures 
were warmed to 37°C. prior to addition of the substrate. Aliquots of 0.2 ml. were withdrawn 
from the reaction mixture immediately after addition of the substrate, and thereafter at  in- 
tervals up to 60 minutes. These samples were transferred to 12 X  75 ram. test tubes containing 
2 ml. of 2.5 per cent trichloracetic acid (TCA) in water, and mixed. The tubes were then centri- 
fuged for 15 minutes at 2,500 l~.P.~. (1,380 lZ.c.r.). The supernatants were poured into 12 X  75 
ram. tubes and the tubes containing the precipates were inverted on filter paper for 20 minutes. 
The radioactivity was counted in all the tubes containing supernatant or precipitate, using a 
well scintillation counter. Enzymatic breakdown of the substrate was measured as the increase 
in the amount of radioactive material soluble in 2.5 per cent TCA. In each sample the per- 
centage of TCA-soluble material was calculated from the expression 
c. P. u. supernate 
c. P. M. supemate plus precipitate 
X  100. 
This measurement was unaffected by small volumetric errors in pipettlng the samples. In- 
itially all assays were run in duplicate, and it was found that the duplicate determinations did 
not differ by more than i or 2 per cent. 
The rate of the reactions, R,  was calculated by expressing the increase in TCA-soluble 
radioactivity between any successive pair of samples as a percentage of the precipitable radio- 
activity in the first of the pair, and dividing this percentage by the number of minutes in the 
interval between the samples. 
The values of R  obtained by this approximation remained fairly constant over a period of 
60 minutes, and were closely related to the concentration of papain (C) in the reaction mixture. 
Over a range of concentrations of papain between 25 micrograms and 1.0 rag. per ml., the rela- 1176  REMOVAL OF  CARTILAGE MATRIX BY  PAPAIN 
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tionship between ~  and %/~ was linear. On this basis, the residual in vitro activity of papain fol- 
lowing  inactivation  procedures  was  recorded  as  the  weight  of  fully  active  papain 
having equivalent activity. 
The amount of chondroitin sulfate released from cartilage was measured by a turbidimetric 
procedure  using hexamminecobaltie chloride.  This  trivalent cation  combines with  certairi 
anionic materials such as chondroitin sulfate to form insoluble complexes in media of low ionic 
strength.  It has been shown that  when chondroitin sulfate is added  to serum or water the 
turbidity produced by the addition of hexamminecobaltic chloride is proportional  to the con- 
centration of chondroitin sulfate within the range of 0.025 to 2.500 mg./ml. The specificity 
and limitations of this method have been described elsewhere  (10).  The procedure may be 
described briefly as follows: 0.4 ml. of the solution to be tested is dialyzed for 48 hours with 2 
changes of distilled water; the contents of the bag are transferred to a 10 X  75 mm. test tube 
and diluted to 2.2 ml. with distilled water; after centrifugafion at 2000 R.P.M. for 10 minutes, 
the supernatant is transferred to a Coleman Jr. spectrophotometer tube 1 and the optical den- 
sity at 615 ram. is measured using distilled water as a blank; 5 minutes after the addition of 0.2 
ml. of a 5 per cent w/v solution of hexamminecobaltic chloride, the optical density is again de- 
termined, and the difference between the first and second readings is recorded as the result in 
absorbance units. 
Rabbits were bled by cardiac puncture and the blood was either transferred to tubes con- 
taining dry ammonium potassium oxalate mixture or allowed to clot in tubes containing no 
anticoagulant.  The animals were sacrificed  by intracardiac injection of nembutal.  Blocks of 
tissue for histologic examination were fixed in 10 per cent buffered formalin and stained  as 
routine with hematoxylin and eosin. 
The distribution of papaln in serum was studied by electrophoresis in 0.8 per cent agar gel. 
Following electrophoresis,  the  serum  proteins  were identified by goat  antiserum  to  whole 
rabbit serum, and papain by rabbit antiserum to papaln. 
In subsequent studies using papain labeled with I TM, the sera were fractionated by starch 
block electrophoresis,  following the method described by Kunkel (11). Barbital buffer,  pH 8.6, 
ionic strength 0.05, was used.  In the eluates from the starch the concentration of protein was 
determined by a  modified Folin technique (11) and the I TM activity was measured in a well 
scintillation counter, using 2 ml. aliquots in 12 X  75 ram. tubes. 
RESULTS 
Reactivation in Vitro of Papain Treated with Iodoacetamide 
The chemical nature  of the active site of papain has been discussed  recently 
by Smith (12). For the purpose of the present report the activity of the enzyme 
can be regarded  as  dependent  on a  sulfhydryl group.  Simple oxidation of  the 
active, reduced  form of papain  (PSH)  leads  to reversible inactivation by con- 
version to the disulfide form (PS--SP).  This product can be reactivated by re- 
ducing agents such as cysteine. Reduced papain is also susceptible to alkylation 
by  agents  such  as  iodoacetamide,  with  the  formation  of  papain  acetamide 
(PS--CH~CONH~),  which  cannot  be reactivated  by  cysteine.  In the disulfide 
form, papain  is resistant  to alkylation by iodoacetamide. 
When  a  solution  of  crystalline  papain  containing  cysteine  is  treated  with 
1 Coleman Instruments,  Inc., Maywood, Illinois. POTTER, MCCLUSKEY, WEISSMANN, AND  THOMAS  1177 
excess iodoacetamide, and the mixture injected intravenously in a rabbit weigh- 
ing less than  1000  gm., widespread depletion of cartilage matrix occurs.  This 
mixture, however, shows no in z~tro enzymatic activity, even following addition 
of excess cysteine. As a  tentative interpretation of these findings, it was previ- 
ously suggested that papain acetamide was reactivated in the rabbit (5). Subse- 
quently an alternative explanation was formulated, according to which the in 
vivo depletion was not the result of reactivation of papain acetamide, but instead 
was due to reactivation, in cartilage, of a portion of the injected enzyme which 
was in the disulfide form. This implied that following intravenous injection of 
the mixture, the excess iodoacetamide was in effect neutralized  or distributed 
elsewhere from the enzyme. 
From this hypothesis,  it follows that when excess iodoacetamide has been 
removed from a solution of papain, some enzymatic activity should be restored 
in vitro by addition of cysteine. Moreover, the in vivo properties of material so 
treated should be identical with those of reduced papain and it should not pro- 
duce depletion of cartilage matrix following intravenous injection.  Finally, re- 
peated  treatment  with  iodoacetamide should  not  progressively diminish  the 
restorable enzymatic activity of papain, unless preceded by measures to convert 
the disulfide portion to the reduced form, and thus make it susceptible to alkyla- 
tion. These predictions were tested as described below. 
A solution of commercial  crystalline papain containing 20 mg./ml. Gf the protease and 0.03 
M  cysteine was diluted with an equal volume of phosphate buffer containing 0.02 ~¢ iodoaceta- 
mide, and incubated at 37°C. for 15 to 30 minutes. The solution was then dialyzed for 24 hours 
at 4°C. with a 200-fold volume of 0.1 x¢ phosphate buffer, pH 7.0, which contained 0.001 x, 
EDTA, to minimize combination of the enzyme with trace metals. The proteolytic activity 
of this material was measured on I  TM labeled HSA. The results of a typical experiment are 
shown in Text-fig. 1. 
After  treatment  with  iodoacetamide  followed  by  dialysis,  papain  showed 
restorable activity equivalent to 30 per cent of the untreated enzyme. When 
this material was again treated with iodoacetamide, and then dialyzed, assay 
on  I131-1abeled HSA showed no further  loss  of restorable activity.  However, 
when the  second treatment  with  iodoacetamide was preceded by incubation 
with cysteine, 0.01 M, the restorable activity was further diminished (Table I, 
lines  1  to  4).  The  proteolytic activity  of a  mixture  of untreated  and  iodo- 
acetamide-treated papain was significantly less than the sum of the two com- 
ponents, indicating that irreversibly inactivated papain may inhibit the active 
enzyme in this system (Table I, line 6). The reaction was also retarded by other 
proteins, such as chondromucoprotein (Table I, lines 7 and 8). 
Although the amount of potentially active enzyme remaining after treatment 
with iodoacetamide may thus be greater than indicated by assay on I131-1abeled 
HSA,  these results  do indicate  that  when treated with  iodoacetamide under 
the conditions described a  substantial proportion of papain may remain in a 1178  REMOVAL  O;F CARTILAGE  MATRIX  BY  PAPAIN 
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T~xT-FIG. 1.  Assay of papaJn protease with iodlne181-labeled  human  serum  albumin  as 
substrate. Each point on the line relating the rate hydrolysis to  the concentration of papain 
(inset) represents the average calculated from successive determinations of the percentage of 
radioactivity soluble in T.C.A. POTTER~  McCLUSKEY~  WEISSMANN~  AND  THOMAS  1179 
reversibly oxidized disulfide form. If this portion is responsible for the depletion 
of cartilage following injection of iodoacetamide treated papain, the addition of 
cysteine to the mixture prior to injection should abolish the in vivo effect on 
cartilage, as in the case of dialyzed papain. 
TABLE I 
Enzymatic Activity of Papain Preparations Measured with Ilal-Labded 
Human Serum Albumin as Substrate 
Enzyme preparation assayed on HSA-I  1  al 
1.  Untreated papain 
2.  Papain (A) treated once with IhA* 
3.  Papaln (A) treated twice with IAA* 
4.  Preparation 2, treated with cysteine,  then with 
IAA* 
5.  Untreated papaln (B) 
6.  Preparation 4, 0.5 nag. 
Preparation 5, 0.5 nag. 
7.  Untreated papaln (C) 
8.  Untreated papaln (C) with CMP,~ 0.5 nag/nal. 
Rate 
reacti( 
j)er ~$~I 
rain,,. 
0.94 
0.45 
0.45 
0.07, 
0.52 
0.40 
1.22 
0.99 
Untreated papain having 
equivalent activity 
Amount  Percentage of 
amount assayed 
mg/ml., C. 
0.5  100 
0.15  30 
0.15  30 
0.005  1.0 
0.19 (A)  100 
0.12  62 
0.69(A)  100 
0.50  72 
The reaction mixtures contained papain, 0.5 mg./nal.,  IlSLlabeled albumin, 0.5 mg./ml., 
cysteine,  0.005 ~, EDTA, 0.001 ~r in phosphate buffer, 0.1 ~, pH 7.0; all were maintained 
at  37°C. without  agitation. 
* IAA, iodoacetamide. For procedure see text. 
CMP, bovine nasal chondromucoprotein. 
Accordingly, a solution of crystalline papain was treated with 0.01 M iodoacetamide for 30 
minutes at 37°C. and dialyzed for 24 hours  to remove  the excess iodoacetamide.  Cysteine 
(0.01 ~) was then added to a portion of the material and this and the remaining portion were 
incubated for 15 minutes at 37°C. The results of intravenous injection of the preparations are 
shown in Table II. 
In the majority of rabbits, unequivocal depletion of cartilage matrix occurred following in- 
jection of iodoacetamide-treated papain; this effect was abolished by the addition of cysteine 
to the mixture prior to injection. 
These  findings  indicate  that  papain  acetamide  is  not  reactivated  in  the 
rabbit and can best be explained by assuming that the effects observed after 
injection result from  the  activation in  cartilage of a  portion of the  injected 
enzyme in  the  disulfide form.  If it were  possible to  treat papain with  iodo- 
acetamide in such  a  way as to form  a  product  consisting entirely of papain 
acetamide with none of the enzyme in the disulfide form, such material should 
have no restorable activity in vitro and no effect on cartilage in vivo. 1180  REMOVAL  OF  CARTILAGE MATRIX  BY  PAPAIN 
Accordingly, a solution of crystalline papain was incubated for 15 minutes after addition of 
cysteine (0.01 u) and EDTA (0.001 M); following  addition of iodoacetamide (0.02 ~J) the mix- 
ture was incubated for a further  60 minutes and then dialyzed for 24 hours at 4°C. with a 
200-fold volume of phosphate buffer. This whole procedure was then repeated. The final pro- 
duct was tested for in vitro proteolytic activity after addition of cysteine and EDTA and the 
results are shown in Table I, line 4. 
An injection consisting of  5  mg.  of  this  preparation without cysteine was 
given to each of 6 rabbits. There was no subsequent loss of rigidity of the ears, 
and the sections of cartilage obtained from 5 of the animals sacrificed 24 hours 
TABLE II 
Effects of Iodoacetamide-Treated Papain on Cartilage in Vivo 
No. of rabbits  with  No. with loss of 
loss of rigidity  basophilia  in 
of ears*  cartilage  matrix~ 
Papain  preparation  injected  intravenously 
--  to  2-[-  to  44- to  --  to  24- to  4+  to 
14-  34-  54-  14-  34-  ]  54- 
Papain treated once with IAA§ 5 rag.  9  4  9  4  [  3  4 
Papain treated once with IAA, then  J 
with cysteine 5 mg  ..............  9  0  0  3  0  0 
Papain treated once with IAA, then  [ 
with cysteine, and again with IAA  r 
5 mg  ..........................  6  0  0  5  1 
i 
* Loss of rigidity:  -- to 1+, no loss, or collapse of distal 1 cm. 
2+ to 3+, collapse of distal 2 to 5 cm. 
4+ to 5+, collapse of distal 6 cm. or more. 
~: Loss of basophilia: -- to 1+, no loss or slight loss. 
2+ to 3+, moderate loss. 
4+ to 5+, marked or complete loss. 
§ IAA, iodoacetamide. 
Average  cobalt 
turbidity  of serum 
18-24 hi 
after pa~  ' 
(OD at 615  a) 
(No. test 
0.239 (22) 
0.097 (9) 
0.165 (6) 
later showed normal basophilic staining of the matrix. In the sixth rabbit some 
hematoxylin and eosin-stained sections of  cartilage showed moderate loss of 
basophilia. There was a moderate increase in the amount of cobalt-precipitable 
material in the  sera  obtained 24 hours  after injection of  this preparation of 
papain, indicating that it did have a  slight effect on cartilage in vivo. 
Factors  Which  Determine  the Difference  between Active  and  Inactive  Papain  in 
Their Effect on Cartilage Following Intravenous  Administration 
On the basis of the preceding observations, it can be assumed that whatever 
method is used to inactivate papain prior to injection, the ensuing changes in 
cartilage result from reactivation of enzyme in the disulfide form. The question 
remains as to why papain injected in the active form fails to have any effect on 
cartilage. It was postulated that in this form the enzyme rapidly combines with POTTER, ~cCLUSKEY, WEISSMANN, AND  THOMAS  1181 
substrates  in  the  circulation and  is  thereby  prevented  from  diffusing into 
cartilage. This possibility was tested by means of an in vitro system designed to 
reproduce the probable sequence of events occurring in vivo. The procedure is 
shown schematically in Text-fig. 2. 
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The skin and subcutaneous tissue were stripped from the lateral smface of ear cartilage 
plates immediately after removal from rabbits weighing between 800 and 1000 gm. The plates 
of cartilage were immersed for 20 minutes at 37°C. in one of the 6 solutions shown in Table III. 
In the  mixtures  containing  papain,  the  enzyme was  mixed with  the  prewarmed  serum 
or Tyrode's solution just before the plates of cartilage were inserted. Mter the initial 20 minute 
period of incubation, the plates were washed with Tyrode's solution to remove traces of papain 
on the surface, and were then transferred to tubes containing Tyrode's solution with cysteine, 
0.005 M, and EDTA, 0.001 ~. Mter 4 hours' incubation  at 37°C. the plates were examined for 
loss of rigidity, and blocks of tissue were fixed for histologic examination. The media surround- 
ing the plates of cartilage were analyzed for material  precipitable  by hexamminecobaltic 
chloride. The results are shown in Table III. 
It was found that the plates of cartilage exposed initially to either active or 
inactive papain in Tyrode's solution both showed considerable loss of rigidity 
and depletion of matrix, as judged by loss of basophilic staining in hematoxylin 1182  REMOVAL  OF  CARTILAGE MATRIX  BY  PAPAIN 
and  eosin  sections.  Approximately  equal  amounts  of  cobalt-precipitable 
material  were  released  into  the  surrounding  media.  Similar  effects were  pro- 
duced  in  the  cartilage  exposed  to  inactive  papain  in  serum.  In  contrast,  the 
cartilage initially exposed to active papain in serum subsequently showed only 
slight  loss of rigidity  and  depletion  of matrix,  and  released  substantially  less 
cobalt-precipitable  material  into  the  medium.  With  minor modifications,  this 
experiment was repeated twice with essentially the same outcome. 
These results show that normal rabbit serum has the property of hindering 
the entry of active papain into cartilage in vitro and they support the interpre- 
TABLE III 
Influence of Rabbit Serum upon Entry of Papain into Cartilage in Vitro 
Solution  in which cartilage was incubated for 
initial 20 rain. period 
Tyrode's solution .............................. 
Serum ........................................ 
Inactive papain[] in Tyrode's solution ............ 
Inactive papainl] in serum ...................... 
Active papain H  in Tyrode's solution ............. 
Active papain[[ in serum ....................... 
Changes  in Cartilage on 
subsequent  incubation for 
4 hrs. in Tyrode's solution* 
Loss of  Loss of 
rigidity~t  basophilia 
in matrix§ 
+q-q-  ++++ 
++q-  ++++ 
+q-q-  q-q-++ 
+  q- 
Increase in 
cobalt turbidity 
of surrounding 
medium at 
4 hrs. 
A O.D. 
0.016 
0.005 
0.166 
0.169 
0.183 
0.080 
* Containing  cysteine 0.005 •  and EDTA 0.001 M. 
Loss of rigidity;  See Table II. 
§ Loss of basophilia;  See Table II. 
I] Concentration  of papain, 100 micrograms/ml. 
tation  that  intravenously  injected  active  papain  fails  to  produce  changes  in 
cartilage because it interacts  with one or more components of serum. 
Rates  of Disappearance  of Fapain from  the Circulation  Following Intravenous 
Injection in Rabbits 
It  was  postulated  that  because  of interaction  with  material  in  the  blood, 
active  papain  would  leave  the  circulation  more  slowly  than  inactive  papain 
following intravenous injection. 
The problem was investigated  using papain labeled  with  I TM.  This material 
was assayed on BAA before and after iodination,  and the amount of dialyzable 
1  TM was measured following activation or inactivation procedures. Samples were 
precipitated  with specific antiserum to test the specificity of the I TM label. The 
results  obtained  with  two  preparations  of labelled  papain  are  listed  in  Table 
IV. POTTER, McCLUSKEY,  WEISSMANN, AND THOMAS  1183 
Amounts of active or inactive papain in the range of 1 to 4 mg./kg, were injected by vein 
into rabbits which weighed approximately 1000 gm. Samples of blood were obtained by cardiac 
puncture at intervals thereafter, and were mixed with dry anticoagulant in tubes immersed 
in an ice bath. The plasma was separated by centrifugation at 4°C. and the radioactivity of 
0.5 ml. samples of plasma was measured in a well scintillation counter. In a number of samples, 
the radioactivity was also measured in the washed cells and in the fibrin clot produced by re- 
calcification  of  the  plasma.  Since  it  was  found  that  the  serum  contained  virtually  all 
of the radioactive material present in samples of whole blood, the data from these experiments 
are presented as concentrations of papain in serum in micrograms/milliliter. 
TABLE IV 
Properties of ll31-Labded Papain 
Specific  enzymatic activity on BAA (Cl) 
Before labeling  After labeling 
Preparation I ......................  0.269  0.188 (70 per cent) 
Preparation II .....................  o. 151  o. 130 (86 per cent) 
Distribution of radioactivity after dialysis following 
activation or inactivation procedures 
Active papain ...................... 
Inactive papain .................... 
Preparation I ...................... 
Preparation II ..................... 
Non-dialyzable 
¢.p.m./mL 
417,345 
420,035 
Dialyzable 
¢.p.m./ml. 
1,655 
2,965 
Distribution of radioactivity after precipitation 
with specific  antiserum  in antibody excess 
Precipitate 
c.p.m./ml. 
5,828 (85 per cent) 
2,100(89 per cent) 
Supematant 
¢.p.m.lraL 
1,029 
270 
As shown in Text-figs. 3  and 4, the rate of disappearance of papain was a 
function of the concentration, and the rates were the same whether the papain 
was active or inactive at the time of injection. It is evident that any tendency 
for inactive papain to diffuse into cartilage more readily than the active enzyme 
was not reflected by a measurable difference in the rates of disappearance from 
the circulation. In view of the possibility that a difference might be apparent 
if the concentration of papain in serum exceeded a  threshold level, 5 rabbits 
were given injections of active or inactive I131-1abeled papain, 5 reg./kilo. The 
three animals given the fully active form of this batch of papain died very soon 
after injection,  and  it  was  therefore impossible  to  compare the  rate  of dis- 1184  REMOVAL  OF CARTILAGE MATRIX BY PAPAIN 
appearance of the inactive preparation with that of an equivalent dose of fully 
active  papain.  Acute  toxic  manifestations  following  administration  of  fully 
active papain in quantities exceeding 5 mg./kg, have been observed frequently; 
the  majority  of  animals  have  shown  no  immediate  untoward  reaction  after 
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TExT-FIG. 3.  Concentration in rabbit  serum of papain  after  intravenous  injection  in the 
active and inactive form. Each point  represents the concentration  of Ilal-labeled  papain  in 
micrograms/ml.,  calculated from the radioactivity  of samples of serum obtained by cardiac 
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administration of lesser amounts of active papain, or after inactive papain in 
amounts up to 10 mg./kg. 
In 2 rabbits, the amount of radioactive material in ear cartilage was measured 
30 minutes after an injection of 4 mg. of Ira-labeled inactive papain; the con- 
centration of papain was estimated to be of the order of 2 micrograms/gin. 
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data shown in Fig. 3  are here plotted as percentages of the initial concentration of papain, 
estimated by extrapolation to zero time on a logarithmic scale of concentration. 
wet weight, and was more than double the estimated amount in cartilage from 
2 rabbits given fully active papain. However, the low level of radioactivity did 
not permit more precise quantitation. 
To test the validity of the data on disappearance rates obtained with I TM- 
labeled papain,  specific  antisera  were  used  to  demonstrate  the  presence  of 
papain in sera withdrawn at intervals following intravenous administration of 
active and inactive papain, labeled or unlabeled. As shown in Text-fig. 5, the 
antigenic similarity between active and inactive papain was established by the 
quantitative precipitin technique. By double diffusion in agar, it was possible 1186  REMOVAL  OF  CARTILAGE  MATRIX  BY  PAPAIN 
to demonstrate the presence of papain in rabbit serum up to 24 hours after a 
single  intravenous injection.  Quantitation  based upon  the  relative intensity 
and position of the precipitin lines corresponding to wells filled with sera ob- 
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nique. The amount of protein in the washed precipitates redissolved in 0.25 ~  acetic add was 
measured as O.D. at 280 mu. Active and inactive papain precipitated equal amounts of anti- 
body. 
tained at various intervals after the administration of papain provided a crude 
measure of rates of disappearance. These rates were entirely compatible with 
the  results  obtained  with  Ira-labeled  papain.  A  typical  example  of  double 
diffusion in agar is shown in Fig. 1. m, 
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electrophoresis  at pH. 8.6, labeled papain alone either remained at the origin or moved towards 
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It was shown that normal rabbit serum impaired the entry of active papain 
into isolated cartilage. Furthermore, in blood withdrawn following intravenous 
injection of I131-1abeled active or inactive papain, almost all of the radioactive 
material remained in serum, little or none being present in the washed cells or 
fibrin clot. As these findings indicated that normal rabbit serum might contain 
one or more components which could combine with papain, the distribution of 
papain in serum was studied by measuring the radioactivity in the fractions 
eluted from starch block electrophoresis of sera obtained following intravenous 
injection of the labeled protease.  In addition,  similar  studies were made  on 
normal rabbit serum to which labeled papain had been added in vitro. It was 
found that the peak concentration of radioactive material was present in the 
fractions corresponding to the alpha globulin zones, and that this distribution 
was the same for both active and inactive labeled papain, whether mixed with 
serum in vitro, or in serum obtained following intravenous administration of the 
labeled protease (Text-fig. 6). In parallel electrophoresis on starch at pH 8.6, 
and  in  the  absence  of serum,  papain  showed  quite  different electrophoretic 
mobility, and moved toward the cathode rather than the anode. These findings 
were confirmed by immuno-electrophoresis of unlabeled papain in saline and in 
serum, using specific antisera to papain and to rabbit serum to identify respec- 
tively the protease and the components of rabbit serum. Thus it appeared that 
both active and inactive papain in concentrations up to 50 micrograms/ml, in 
serum were bound to protein in the alpha globulin region. Additional studies 
with more prolonged electrophoresis, and the preparation of a larger number of 
fractions from the same block, have shown a peak concentration corresponding 
to the alpha~ globulin fraction. In some experiments papain was incubated with 
fractions of normal  serum  which  were  then  subjected  to  electrophoresis on 
starch. It was found that the mobility of papain was modified by the alpha, 
globulin fraction, and not by gamma globulin; the albumin fraction retained 
only 20 per cent of the radioactivity. 
Concentration of Papain Required for in Vitro Depletion of Cartilage Matrix 
In view of the evidence indicating that the amount of papain entering carti- 
lage  after  intravenous  injection  might  not  exceed  2  micrograms/gm,  wet 
weight,  it  was  necessary to determine the  amount  of papain  which in vitro 
would produce changes in cartilage comparable with those seen in vivo. 
The skin and connective tissue were stripped from ears removed from rabbits weighing ap- 
proximately 800 gm. The plates of cartilage were incubated at 37°C. for 4 hours in 0.1 ~  phos- 
phate  buffer,  pit.  7.0,  40  ml.,  containing  0.005  ~  eysteine,  0.001  ~  EDTA.,  and 
crystalline papain in concentrations in the range of 0.2  to  10.0  micrograms/ml. The plates 
were then examined for loss of rigidity, and blocks of tissue were fixed  for histologic  examina- 
tion. The media were analyzed for material precipltable with hexamminecobaific chloride 
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It was found that a detectable loss of rigidity occurred in cartilage exposed 
to papain in concentrations as low as 2 micrograms/ml. 
A more detailed and quantitative study of the diffusion of papain into iso- 
lated cartilage is in progress, and preliminary findings indicate that, in circum- 
stances  similar  to  the  foregoing experiment,  the  concentration of papain  in 
cartilage  attains  levels  only slightly  in  excess  of  those  in  the  surrounding 
media. 
TABLE V 
Effects of Active Crystalline Papain on Cartilage in Vitro 
Concentration of papaln 
in medium 
mlcrograms/ml. 
10 
8 
6 
4 
2 
1 
0.5 
0.2 
Nil 
Changes in cartilage after 4 hrs. at 37°C. 
Loss of rigidity*  Loss of basophilia 
in matrix~ 
++ 
++ 
+ 
-4- 
4- 
4- 
+++ 
++ 
+ 
+ 
+ 
4- 
Increase in cobalt turbidity 
of surrounding medium 
at 4 hrs. 
A O.D. 
0.069 
0.048 
0.017 
0.015 
* Loss of rigidity, see Table II. 
Lo~ of basophilia, see Table II. 
DISCUSSION 
On the basis of the observation that depletion of cartilage matrix occurred in 
rabbits following the intravenous administration of papain treated with excess 
iodoacetamide,  it  was  previously  postulated  that  reactivation  of  papain 
acetamide occurred in the intact animal. However, the inactivation of crystal- 
line papain by iodoacetamide is not reversed in vitro upon addition of reducing 
agents  such  as  cysteine,  and  is  generally stated  to  be  irreversible.  For  this 
reason, it was decided that some alternative explanation should be found. The 
possibility was considered that when papain is incubated with iodoacetamide, 
a portion of the enzyme which is in the disulfide form escapes alkylation, and 
that this portion is responsible for the effects observed in vivo. The validity of 
this explanation was confirmed by the results of three lines of investigation. 
First, it was shown that following dialysis to remove the excess iodoacetamide 
from a  solution of papain, some proteolytic activity was restorable upon the 
addition of cysteine. Second, it was found that when cysteine was added to a 
solution  of papain  from  which  excess  iodoacetamide had  been  removed by 1190  REMOVAL  OF CARTILAGE MATRIX BY PAPA.IN 
dialysis, the product did not produce in vivo depletion of cartilage, and thus 
behaved in this respect like fully active papain. Third, when steps were taken 
to  increase  the  percentage  of enzyme converted to  the  acetamide form by 
repeated exposure to cysteine and excess iodoacetamide, the product obtained 
had considerable less restorable proteolytic activity and its effect on cartilage 
in vivo was diminished. 
It is relevant to note that the residual in vivo effectiveness of papain treated 
with iodoacetamide was greater than might be expected on the basis of restor- 
able  activity of  the  same  preparations  measured by assay on  HSA  I TM.  A 
possible explanation for this disparity could be the observation that the en- 
zymatic degradation of this substrate by active papain was retarded by the 
addition of iodoacetamide-treated papain. While the exact mechanism of this 
inhibitory effect is not known, it is evident that the proportion of active papain 
present  in a  mixture with inert protease  may be  considerably greater  than 
indicated by assay on HSA Im. Alternatively, it is possible that the simul- 
taneous injection of inert papain acetamide may facilitate the  entry of the 
potentially active protease into cartilage in vivo. 
The demonstration that normal rabbit serum impaired the entry into carti- 
lage of active papain, and not of inactive, provides a  basis for explaining the 
difference between the effects of active and inactive papain on cartilage in vivo 
when given intravenously. As was shown previously, the intravenous injection 
of inactive papain into young rabbits results in widespread depletion of carti- 
age matrix, whereas an injection of fully active papain has virtually no effect 
on cartilage. It is thus likely that following intravenous injection, active papain 
rapidly interacts with one or more protein components of serum and as a result 
the  passage  of  the  enzyme into  cartilage  in  amounts sufficient to  produce 
depletion is prevented. On the other hand, a larger amount of inactive papain 
remains free, following intravenous injection, to leave the circulation and enter 
cartilage; the widespread depletion of cartilage matrix observed is presumed to 
be the result of reactivation of the enzyme in this tissue. Using papain labelled 
with D  a, it has been demonstrated that a significantly greater amount is present 
in cartilage following injection in the inactive than in the active form. While 
the amount of enzyme found in cartilage following injection of inactive papain 
represented at most 2 micrograms of enzyme/gin, wet weight of cartilage, it 
has been shown that such a concentration is sufficient to produce depletion of 
isolated cartilage. 
The concentration of 2 micrograms of papain/gm, wet weight of cartilage 
was demonstrated at a time when the concentration in the circulation was over 
50 micrograms/ml, of serum. Thus it is evident that the enzyme is not selec- 
tively taken up by cartilage despite the observation that histological changes 
occur regularly in this tissue only. 
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chondromucoprotein by very small  amounts of  the  enzyme  (13),  it  would 
appear that this substrate undergoes profound physical changes as a result of 
the cleavage of relatively few bonds. Evidence that the change in the viscosity 
of chondromucoprotein observed under these conditions actually results from 
enzymatic splitting of the molecule has been obtained by differential alcohol 
fractionation of the products. It is noteworthy that papain may continue to 
circulate for several hours in such a high concentration without apparent harm 
to the animal, in spite of the fact that an intradermal injection of comparable 
amounts of the enzyme has been found to produce localized necrosis of skin 
(14). 
From  the  foregoing evidence  that  only a  small  fraction  of  the  injected 
material enters cartilage it is not surprising that no difference was demonstrable 
in the rate  of disappearance from the circulation of the active and inactive 
forms of the enzyme. On the basis of the data obtained using papain labeled 
with I m, it was found that about 40 per cent of the material left the blood 
within the first 20 or 30 minutes following injection and it is reasonable to 
assume that this loss represents equilibration with the extracellular space. If 
this is true, it is necessary to postulate that the failure of active papain to 
enter cartilage depends on interaction not only with serum components within 
the circulation but also with components within the extraceUular space. 
The interaction of papain with components of serum was studied by means 
of  immuno-electrophoresis and  zone electrophoresis in starch.  It was found 
that the electrophoretic mobility of papain was altered in serum and that in 
concentrations up  to  50  micrograms/ml, of serum,  the enzyme moved with 
protein in the alpha globulin region.  Since this effect was the same whether 
papain was mixed with serum in either the active or inactive form, it may well 
be that this localization in serum has no direct bearing on the observed differ- 
ences in effects between active and inactive papain following intravenous injec- 
tion. It seems likely that the portion of the enzyme which disappears from the 
circulation in the first few minutes is not bound by this fraction of serum and 
that it is the difference in handling of the unbound portion of the enzyme that 
accounts for the difference in the effects on cartilage of active and inactive 
papain injected by vein. As already stated, it would appear that this difference 
depends on the interaction between the active enzyme and proteins in the inter- 
stitial space, perhaps as the result of enzyme-substrate combination. 
While the foregoing observations on the fate and distribution of papain in 
the rabbit are concerned with the way in which a particular foreign enzyme is 
handled, they may have bearing on the way in which other potentially harmful 
enzymes are prevented from causing damage to tissues. Following entry into 
the circulation, bacterial or tissue enzymes may also selectively combine with 
alpha globulin or other protein and as a result may be prevented from entering 
and injuring tissue. 1192  REMOVAL  OF CARTILAGE  MATRIX  BY PAI'AIR 
SUMMARY 
In rabbits,  the depletion of cartilage matrix which occurs following intra- 
venous administration of papain treated with iodacetamide is attributable to a 
portion of the enzyme in the disulfide form which has not undergone alkylation. 
It is this portion that is reactivated in cartilage in v/vo and initiates the enzy- 
matic breakdown of the protein-polysaccharide complex which forms a major 
component of the matrix. Evidence presented in support of these conclusions 
indicates that, contrary to an earlier hypothesis, papain acetamide is not reac- 
tivated/n vivo. 
Following intravenous injection in  amounts up  to  4  mg./kg.,  active  and 
inactive papain leaves the circulation at a rate proportional to the concentra- 
tion, and it is likely that the initial rate of disappearance represents equilibra- 
tion with the extracellular space. Following injection in the active or inactive 
form, a  high proportion of papain in serum is bound to protein in the alpha 
globulin fraction. It is believed that in the case of fully active papain, the pro- 
portion which is not bound to alpha globulin becomes attached to other pro- 
teins of serum in extracellular fluid, such as albumin, by a process of enzyme 
substrate combination, and is thus prevented from diffusing into cartilage. In 
the case of inactive papain, a comparable excess remains free to enter cartilage, 
where it initiates depletion of matrix following reactivation within the tissue. 
These  conclusions  provide  an  explanation  for  the  failure  of  fully active 
papain to cause depletion of cartilage matrix in v/vo; the widespread changes 
seen after the injection of papain inactivated by iodoacetamide or by simple 
reversible  oxidation are  attributable  to  a  small  proportion  of  the  injected 
material which  enters  cartilage  in  the  disulfide form in  a  concentration of 
approximately 2 micrograms/gm, wet weight. The possibility that such a small 
amount of protease, when reactivated, can produce changes in cartilage matrix 
has been confirmed by studies on the effects of papain on isolated cartilage and 
chondrornucoprotein in v/tro. 
It has  been shown that severe  local injury results when active papain  is 
injected into the skin of a  rabbit in low concentrations. Since a  much higher 
concentration of papain  can  be  attained in  the  circulation without obvious 
adverse effects, it is evident that binding of the protease by alpha globulin and 
possibly other serum proteins may exemplify a mechanism whereby the tissues 
are protected from injury following entry into the circulation of other poten- 
tially harmful agents, such as proteolytic enzymes derived from cells or bac- 
teria. 
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EXPLANATION  OF PLATE 96 
FIG. I. Double-diffusion  in agar of serum obtained from rabbits  following  intra- 
venous papain. Center wells,  12: rabbit  anti-papain  serum. Peripheral wells, I, 2, 3, 
and 4: sera  obtained 5 minutes, 1 hour, 4 hours,  and 12 hours after  injection  of inac- 
tive  papain.  Peripheral  wells,  7,  8,  9, and 10:  sera  obtained 5 minutes, l  hour,  4 hours, 
and 12 hours after  injection  of  active  papain. Peripheral  wells  5 and I  l  :  sera  obtained 
just before injection  of papain. Peripheral  wells  6: normal rabbit serum containing 
papain, 40 micrograms/ml., mixed in vitro. THE  JOURNAL  OF  EXPERIMENTAL  MEDICINE  VOL.  112  PLATE  96 
FIG,  I 
(Potter et al.: Removal of cartilage matrix by papain) 